Fact CheckerSign in

NCT07707583Enrolling by invitation

Heart Rate Variability and Medication Adherence in Resistant Hypertension

Eart Rate Variability, Medication Adherence, and Blood Pressure Control in Resistant Hypertension: A Cross-Sectional Study

Source: ClinicalTrials.gov · Last updated 27 Oct 2026

Brief summary (registry, in English)

This single-center, cross-sectional observational study examines the relationship between adherence to antihypertensive therapy - verified objectively by therapeutic drug monitoring (TDM) - and heart rate variability (HRV) in patients with resistant hypertension. Patients are recruited opportunistically, in a nurse-led manner, in a one-day-care cardiology unit, and undergo a single examination: a short-term HRV recording (Polar H10), a single blood draw for antihypertensive drug levels, office blood pressure, and self-completed questionnaires. There is no follow-up.

Status (registry)
Enrolling by invitation
Study type
Observational
Enrollment
150 (estimated)
First submitted
13 Jul 2026
Start date
26 Oct 2026
Primary completion date
26 Nov 2027
Lead sponsor
Nemocnice AGEL Trinec-Podlesi a.s.
NCT number
NCT07707583

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 26 Oct 2026 to the primary completion date, 26 Nov 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Absence of sinus rhythm: atrial fibrillation/flutter, ventricular arrhythmias, higher-degree AV block, pacemaker/ICD with sustained pacing, sustained SVT, or significant ectopy
  • Secondary hypertension
  • Cognitive impairment precluding informed consent

Other

  • Pregnancy or breastfeeding

Who the study is looking for

  • Age 18-75 years with diagnosed essential hypertension
  • Treated with ≥3 antihypertensive drugs of different classes, including ≥1 diuretic (resistant hypertension)
  • Sinus rhythm
  • Able to give informed consent and understand Czech

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Nemocnice AGEL Třinec-Podlesí a.s.
Coordinator of this site? Confirm its status
TřinecCzechiaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.